Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro
In today’s Pharmaceutical Executive Daily, the FDA approves a monthly dosing schedule for Rybrevant Faspro, HHS Secretary Robert F. Kennedy Jr. revis…
3 months ago
Pharmaceutical Executive Daily: Disc Medicine Receives CRL from FDA for Bitopertin
In today’s Pharmaceutical Executive Daily, the FDA issues a Complete Response Letter for Disc Medicine’s bitopertin in EPP, Edwards Lifesciences lift…
3 months ago
Pharmaceutical Executive Daily: Eli Lilly's $1.5 Billion Stockpile of Orforglipron
In today’s Pharmaceutical Executive Daily, Eli Lilly builds a $1.5 billion stockpile of Orforglipron ahead of an FDA decision, PTC Therapeutics withd…
3 months, 1 week ago
Pharmaceutical Executive Daily: FDA Issues Refusal-to-File Letter to Moderna
In today’s Pharmaceutical Executive Daily, the FDA issues a refusal-to-file letter to Moderna for its seasonal influenza vaccine as the company secur…
3 months, 1 week ago
Pharmaceutical Executive Daily: Specialized Wealth Management for BioPharmaceutical Sales
In today’s Pharmaceutical Executive Daily, frontline biopharma sales professionals are increasingly turning to specialized wealth management advisory…
3 months, 1 week ago
Bets and Balances: Riding the Risk-and-Innovation Pendulum in Biotech
In a podcast conversation with Pharm Exec, Ken Banta, founder and CEO of The Vanguard Network, and Andrew Hall, CEO of Consano Bio, discuss what eff…
3 months, 1 week ago
Pharmaceutical Executive Daily: Hims & Hers Removes Access to New Compounded Semaglutide Pill
In today’s Pharmaceutical Executive Daily, Hims & Hers withdraws access to its compounded semaglutide pill following a controversy filled launch, nex…
3 months, 1 week ago
Pharmaceutical Executive Daily: The Launch of TrumpRx
In today’s Pharmaceutical Executive Daily, TrumpRx officially launches, the FDA moves against mass marketing of illegal copycat drugs, and AI emerges…
3 months, 2 weeks ago
Pharmaceutical Executive Daily: FDA Approves First and Only Oral Film Treatment for Erectile Dysfunction
In today’s Pharmaceutical Executive Daily, FDA approves Vybrique for erectile dysfunction, experts argue Phase III clinical protocols should be treat…
3 months, 2 weeks ago
Pharmaceutical Executive Daily: Susan G. Komen Releases Breast Cancer Outlook for 2026
In today’s Pharmaceutical Executive Daily, Susan G. Komen releases its 2026 breast cancer progress outlook, industry leaders explore how pharma can t…
3 months, 2 weeks ago